Cargando…
Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
ABSTRACT: Serology assays are essential tools to mitigate the effect of COVID-19, help to identify previous SARS-CoV-2 infections or vaccination, and provide data for surveillance and epidemiologic studies. In this study, we report the production and purification process of the receptor-binding doma...
Autores principales: | Rodríguez, María Celeste, Ceaglio, Natalia, Gugliotta, Agustina, Villarraza, Javier, Garay, Ernesto, Fuselli, Antonela, Gastaldi, Victoria, Tardivo, María Belén, Antuña, Sebastián, Fontana, Diego, Prieto, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638423/ https://www.ncbi.nlm.nih.gov/pubmed/36329132 http://dx.doi.org/10.1007/s00253-022-12254-w |
Ejemplares similares
-
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes
por: Garay, Ernesto, et al.
Publicado: (2023) -
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes
por: Villarraza, Javier, et al.
Publicado: (2023) -
Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
por: Villafañe, Luciana, et al.
Publicado: (2022) -
Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021) -
Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening
por: Srivastava, Ashish Kumar, et al.
Publicado: (2022)